Abstract
Purpose
The main aim of our study was to evaluate the benefit of the use of non-apoptotic spermatozoa selected by magnetic-activated cell sorting (MACS) for ICSI procedures for couples in which the women had good prognoses and the male factor of infertility was teratozoospermia.
Methods
Twenty-six couples were treated with ICSI after MACS selection of non-apoptotic spermatozoa following a sibling oocyte approach. Half of the oocytes were microinjected with conventionally prepared spermatozoa, and the other half were microinjected with non-apoptotic, MACS-selected spermatozoa. To assess the influence of MACS selection of spermatozoa on the outcomes of the ICSI cycles, the fertilization, embryo quality, pregnancy, and delivery rates were evaluated and compared between the sibling oocyte groups.
Results
When subpopulations of couples according to female age were analyzed, a significant difference in quality of blastocyst was observed. More precisely, in a group that was treated with MACS-ICSI, a higher percentage of good quality blastocysts was found among women older than 30 years (75.0 vs. 33.3%; P = 0.028), while there was no difference among younger women. If all included couples were compared regardless of age, no significant difference was observed in the outcome of the ICSI/MACS-ICSI cycles in terms of oocytes and embryos. Additionally, after the ICSI and MACS-ICSI procedures, the morphologies of the prepared spermatozoa were compared. Results showed that the overall percentage of morphologically normal spermatozoa did not differ significantly between the ICSI and MACS-ICSI procedures. However, detailed analyses of the morphologically abnormal spermatozoa revealed significantly more spermatozoa with abnormal tails after MACS-ICSI procedure, which may be potential consequence of the selection procedure. Moreover, the trends towards less spermatozoa with abnormal heads and towards more spermatozoa with abnormal necks and midpieces after MACS-ICSI procedure were revealed, although the differences were not significant.
Conclusions
Couples dealing with male infertility due to teratozoospermia can benefit from MACS selection of spermatozoa with higher percentage of good quality blastocysts but only when the woman is older than 30 years.
Similar content being viewed by others
References
World Health Organization. WHO Laboratory manual for the examination and processing of human semen. 5th ed. Geneva: WHO Press; 2010.
Bartoov B, Berkovitz A, Eltes F, Kogosowski A, Menezo Y, Barak Y. Real-time fine morphology of motile human sperm cells is associated with IVF-ICSI outcome. J Androl. 2002;23:1–8.
Knez K, Zorn B, Tomazevic T, Vrtacnik-Bokal E, Virant-Klun I. The IMSI procedure improves poor embryo development in the same infertile couples with poor semen quality: a comparative prospective randomized study. Reprod Biol Endocrinol. 2011;9:123.
Knez K, Tomazevic T, Zorn B, Vrtacnik-Bokal E, Virant-Klun I. Intracytoplasmic morphologically selected sperm injection improves development and quality of preimplantation embryos in teratozoospermia patients. Reprod BioMed Online. 2012;25:168–79.
Knez K, Tomazevic T, Vrtacnik-Bokal E, Virant-Klun I. Developmental dynamics of IMSI-derived embryos: a time-lapse prospective study. Reprod BioMed Online. 2013;27:161–71.
Shalom-Paz E, Anabusi S, Michaeli M, Karchovsky-Shoshan E, Rothfarb N, Shavit T, et al. Can intra cytoplasmatic morphologically selected sperm injection (IMSI) technique improve outcome in patients with repeated IVF-ICSI failure? a comparative study. Gynecol Endocrinol. 2015;31:247–51.
Setti AS, Braga DP, Figueira RC, Iaconelli A Jr, Borges E. Intracytoplasmic morphologically selected sperm injection results in improved clinical outcomes in couples with previous ICSI failures or male factor infertility: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;183:96–103.
Gatimel N, Parinaud J, Leandri RD. Intracytoplasmic morphologically selected sperm injection (IMSI) does not improve outcome in patients with two successive IVF-ICSI failures. J Assist Reprod Genet. 2016;33:349–55.
Fortunato A, Boni R, Leo R, Nacchia G, Liguori F, Casale S, et al. Vacuoles in sperm head are not associated with head morphology, DNA damage and reproductive success. Reprod BioMed Online. 2016;32:154–61.
Teixeira DM, Barbosa MA, Ferriani RA, Navarro PA, Raine-Fenning N, Nastri CO, et al. Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction. Cochrane Database Syst Rev. 2013;7:CD010167.
Maettner R, Sterzik K, Isachenko V, Strehler E, Rahimi G, Alabart JL, et al. Quality of human spermatozoa: relationship between high-magnification sperm morphology and DNA integrity. Andrologia. 2014;46:547–55.
Hammoud I, Boitrelle F, Ferfouri F, Vialard F, Bergere M, Wainer B, et al. Selection of normal spermatozoa with a vacuole-free head (x6300) improves selection of spermatozoa with intact DNA in patients with high sperm DNA fragmentation rates. Andrologia. 2013;45:163–70.
Wilding M, Coppola G, di Matteo L, Palagiano A, Fusco E, Dale B. Intracytoplasmic injection of morphologically selected spermatozoa (IMSI) improves outcome after assisted reproduction by deselecting physiologically poor quality spermatozoa. J Assist Reprod Genet. 2011;28:253–62.
Garolla A, Sartini B, Cosci I, Pizzol D, Ghezzi M, Bertoldo A, et al. Molecular karyotyping of single sperm with nuclear vacuoles identifies more chromosomal abnormalities in patients with testiculopathy than fertile controls: implications for ICSI. Hum Reprod. 2015;30:2493–500.
Lavolpe M, Lorenzi D, Greco E, Nodar F, Alvarez SC. Relationship between sperm DNA fragmentation and nuclear vacuoles. JBRA Assist Reprod. 2015;19:70–4.
Oosterhuis GJ, Mulder AB, Kalsbeek-Batenburg E, Lambalk CB, Schoemaker J, Vermes I. Measuring apoptosis in human spermatozoa: a biological assay for semen quality? Fertil Steril. 2000;74:245–50.
Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995;184:39–51.
Grunewald S, Paasch U. Sperm selection for ICSI using annexin V. Methods Mol Biol. 2013;927:257–62.
Rawe VY, Boudri HU, Alvarez Sedó C, Carro M, Papier S, Nodar F. Healthy baby born after reduction of sperm DNA fragmentation using cell sorting before ICSI. Reprod BioMed Online. 2010;20:320–3.
Bucar S, Gonçalves A, Rocha E, Barros A, Sousa M. Sá R. DNA fragmentation in human sperm after magnetic-activated cell sorting. J Assist Reprod Genet. 2015;32:147–54.
Grunewald S, Baumann T, Paasch U, Glander HJ. Capacitation and acrosome reaction in nonapoptotic human spermatozoa. Ann N Y Acad Sci. 2006;1090:138–46.
de Vantéry Arrighi C, Lucas H, Chardonnens D, de Agostini A. Removal of spermatozoa with externalized phosphatidylserine from sperm preparation in human assisted medical procreation: effects on viability, motility and mitochondrial membrane potential. Reprod Biol Endocrinol. 2009;7:1.
Dirican EK, Ozgün OD, Akarsu S, Akin KO, Ercan O, Uğurlu M, et al. Clinical outcome of magnetic activated cell sorting of non-apoptotic spermatozoa before density gradient centrifugation for assisted reproduction. J Assist Reprod Genet. 2008;25:375–81.
Sánchez-Martín P, Dorado-Silva M, Sánchez-Martín F, González Martínez M, Johnston SD, Gosálvez J. Magnetic cell sorting of semen containing spermatozoa with high DNA fragmentation in ICSI cycles decreases miscarriage rate. Reprod BioMed Online. 2017;34:506–12.
Gil M, Sar-Shalom V, Melendez Sivira Y, Carreras R, Checa MA. Sperm selection using magnetic activated cell sorting (MACS) in assisted reproduction: a systematic review and meta-analysis. J Assist Reprod Genet. 2013;30:479–85.
Romany L, Garrido N, Motato Y, Aparicio B, Remohí J, Meseguer M. Removal of annexin V-positive sperm cells for intracytoplasmic sperm injection in ovum donation cycles does not improve reproductive outcome: a controlled and randomized trial in unselected males. Fertil Steril. 2014;102:1567–75.e1.
Golob B, Poljak M, Verdenik I, Kolbezen Simoniti M, Vrtacnik Bokal E, Zorn B. High HPV infection prevalence in men from infertile couples and lack of relationship between seminal HPV infection and sperm quality. Biomed Res Int. 2014;2014:956901.
Kruger TF, Menkveld R, Stander FS, Lombard CJ, Van der Merwe JP, van Zyl JA, et al. Sperm morphologic features as a prognostic factor in in vitro fertilization. Fertil Steril. 1986;46:1118–23.
Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73:1155–8.
Buzzi J, Valcarcel A, Lombardi E, Oses R, Rawe V, Young E. Magnetic activated cell sorting (MACS) improves oocyte donation results associated to severe male factor infertility. Hum Reprod. 2010;25(suppl 1):i118–52.
San Celestino M, Agudo D, Alonso M, Sanjurjo P, Becerra D, Bronet F, et al. Improved pregnancy rate after sperm magnetic separation technique in egg donation cycles using frozen sperm samples. Hum Reprod. 2011;26(suppl 1):i123–48.
Troya J, Zorrilla I. Annexin V-MACS in infertile couples as method for separation of sperm without DNA fragmentation. JBRA Assist Reprod. 2015;19:66–9.
Cakar Z, Cetinkaya B, Aras D, Koca B, Ozkavukcu S, Kaplanoglu İ, et al. Does combining magnetic-activated cell sorting with density gradient or swim-up improve sperm selection? J Assist Reprod Genet. 2016;33:1059–65.
Mrkun J, Dolensek T, Knific T, Pislar A, Kosec M, Kos J, et al. Elimination of apoptotic boar spermatozoa using magnetic activated cell sorting. Acta Vet Brno. 2014;83:13–8.
Said TM, Grunewald S, Paasch U, Glander HJ, Baumann T, Kriegel C, et al. Advantage of combining magnetic cell separation with sperm preparation techniques. Reprod BioMed Online. 2005;10:740–6.
Aziz N, Said T, Paasch U, Agarwal A. The relationship between human sperm apoptosis, morphology and the sperm deformity index. Hum Reprod. 2007;22:1413–9.
Nadalini M, Tarozzi N, Di Santo M, Borini A. Annexin V magnetic-activated cell sorting versus swim-up for the selection of human sperm in ART: is the new approach better then the traditional one? J Assist Reprod Genet. 2014;31:1045–51.
Curti G, Skowronek F, Vernochi R, Rodriguez-Buzzi AL, Rodriguez-Buzzi JC, Casanova G, et al. Morphological evaluation of sperm from infertile men selected by magnetic activated cell sorting (MACS). Reprod Biol. 2014;14:289–92.
Ménézo Y, Dale B, Cohen M. DNA damage and repair in human oocytes and embryos: a review. Zygote. 2010;18:357–65.
Barroso G, Valdespin C, Vega E, Kershenovich R, Avila R, Avendaño C, et al. Developmental sperm contributions: fertilization and beyond. Fertil Steril. 2009;92:835–48.
Schulte RT, Ohl DA, Sigman M, Smith GD. Sperm DNA damage in male infertility: etiologies, assays, and outcomes. J Assist Reprod Genet. 2010;27:3–12.
Speyer BE, Pizzey AR, Ranieri M, Joshi R, Delhanty JD, Serhal P. Fall in implantation rates following ICSI with sperm with high DNA fragmentation. Hum Reprod. 2010;25:1609–18.
Zini A, Boman JM, Belzile E, Ciampi A. Sperm DNA damage is associated with an increased risk of pregnancy loss after IVF and ICSI: systematic review and meta-analysis. Hum Reprod. 2008;23:2663–8.
Titus S, Li F, Stobezki R, Akula K, Unsal E, Jeong K, et al. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans. Sci Transl Med. 2013;5:172ra21.
Degheidy T, Abdelfattah H, Seif A, Albuz FK, Gazi S, Abbas S. Magnetic activated cell sorting: an effective method for reduction of sperm DNA fragmentation in varicocele men prior to assisted reproductive techniques. Andrologia. 2015;47:892–6.
Vendrell X, Ferrer M, García-Mengual E, Muñoz P, Triviño JC, Calatayud C, et al. Correlation between aneuploidy, apoptotic markers and DNA fragmentation in spermatozoa from normozoospermic patients. Reprod BioMed Online. 2014;28:492–502.
Esbert M, Godo A, Soares SR, Florensa M, Amorós D, Ballesteros A, et al. Spermatozoa with numerical chromosomal abnormalities are more prone to be retained by Annexin V-MACS columns. Andrology. 2017;5:807–13.
Khalid SN, Qureshi IZ. Pregnancy rate improves in couples with unexplained infertility following intrauterine insemination (IUI) with magnetically selected non-apoptotic sperms. Fertil Steril. 2011;96:S25.
Acknowledgements
The authors would like to thank all gynecologists, clinical embryologists, medical nurses, and other staff of the Reproductive Unit, Department of Obstetrics and Gynecology, University Medical Centre Ljubljana, for all the support. We would like to thank also our Andrology Laboratory for the semen analysis.
Funding
The study was funded with tertiary project of University Medical Centre Ljubljana, Slovenia, granted to Dr. Martin Stimpfel.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interests.
Rights and permissions
About this article
Cite this article
Stimpfel, M., Verdenik, I., Zorn, B. et al. Magnetic-activated cell sorting of non-apoptotic spermatozoa improves the quality of embryos according to female age: a prospective sibling oocyte study. J Assist Reprod Genet 35, 1665–1674 (2018). https://doi.org/10.1007/s10815-018-1242-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-018-1242-1